NEW DELHI: Gains in shares of Divi’s Laboratories (up 2.94 per cent), Lupin (up 2.30 per cent) and Cadila Healthcare (up 1.79 per cent) lifted Nifty Pharma index up in morning trade on Thursday.
Lupin’s US arm is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market, USFDA said. The product being recalled by Lupin Pharmaceuticals Inc is in the strength of 10mg, the US health regulator said in an Enforcement Report.
The Nifty Pharma index was trading 0.97 per cent up at 10,047 around 10:30 am.
Dr. Reddy’s Laboratories (up 1.74 per cent), Cipla (up 1.71 per cent) and Aurobindo Pharma (up 1.66 per cent) too were trading with gains.
However, Piramal Enterprises (down 0.96 per cent) and Glenmark Pharmaceuticals (down 0.30 per cent) were trading in the red, whereas shares of Sun Pharmaceutical Industries (up 0.09 per cent) and Biocon (up 0.01 per cent) were almost flat around that time.
Market came down from record highs on selling in bank, metal and auto stocks.
Benchmark NSE Nifty50 index was down 9 points at 11,561, while the BSE Sensex was 7 points down at 38,279.25.
Among the 50 stocks in the Nifty index, 25 were trading in the green, while 25 were in the red.
HDFC, Hindustan Unilever and Reliance Industries were trading up in the Nifty index.
